Manulife (Manufacturers Life Insurance)
TOVX icon

Manulife (Manufacturers Life Insurance)’s Theriva Biologics TOVX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio TOVX Stock Details TOVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-42
Closed -$3 – 3182
2021
Q4 		$3 Sell
42
-52
-55% -$4.9K ﹤0.01% 3106
2021
Q3 		$11K Hold
94
– – ﹤0.01% 3134
2021
Q2 		$14K Buy
+94
New +$13.5K ﹤0.01% 3211
2017
Q3 		– Hold
0
– -$2K – 4335
2017
Q2 		– Hold
0
– – – 4139
2017
Q1 		– Hold
0
– – – 3959
2016
Q4 		– Sell
-2
Closed -$20.5K – 4124
2016
Q3 		$32K Sell
2
-5
-71% -$74.8K ﹤0.01% 3486
2016
Q2 		$106K Buy
+7
New +$132K ﹤0.01% 3194
2016
Q1 		– Hold
0
– – – 3719
2015
Q4 		– Hold
0
– – – 3914
2015
Q3 		– Hold
0
– – – 3945
2015
Q2 		– Hold
0
– -$8 – 4106
2015
Q1 		– Hold
0
– – – 3588
2014
Q4 		– Hold
0
– – – 3557
2014
Q1 		– Hold
0
– -$1 – 3834
2013
Q4 		– Hold
0
– – – 3753
2013
Q3 		– Hold
0
– – – 3612

Other funds holding TOVX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s TOVX Position: Q1 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Theriva Biologics (TOVX) in Q1 2022, closing a stake of 42 shares — an estimated $3 sold.

Manulife (Manufacturers Life Insurance) first reported a position in TOVX in Q2 2016 and held it in 5 quarters. The position peaked at $106K in Q2 2016. 32 funds tracked by Wall St. Rank hold TOVX as of Q1 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Theriva Biologics position as of Q1 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 42 Theriva Biologics shares in Q1 2022, an estimated $3.
  • Manulife (Manufacturers Life Insurance) first reported a position in Theriva Biologics in Q2 2016 and held it in 5 quarters.
  • Manulife (Manufacturers Life Insurance)'s Theriva Biologics position peaked at $106K in Q2 2016.
  • 32 funds tracked by Wall St. Rank held Theriva Biologics as of Q1 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2022, filed 20 May 2022.